Why did SHPH stock move up on 2026-08-05?
In plain English
No clear news behind the move — this looks driven by momentum rather than a specific catalyst.
What it means for you
Finished the day strong — closed near its highs on heavy volume. Risk level: moderate.
Where this comes from
Observed market data. The price, percentage move, open, close and volume above are end-of-day figures for 2026-08-05 from XNAS, not estimates.
No confirmed catalyst. The news feed returned no article for this ticker around this date. That does not mean nothing happened — only that we found nothing we can source, so we are not going to invent a reason.
Price history
274 daily closes through 2026-09-18. End-of-day data — not live prices.
Where SHPH sits in its 52-week range
Context for how far SHPH has moved over the past year — not a signal about where it goes next.
SHPH move history
Every other day we have recorded SHPH moving at least 15% on heavy volume. Dates, prices and volumes are end-of-day market data; the catalyst column links the news article that existed for that date, or says so when none did.
| Date | Move | Close | Volume | Catalyst |
|---|---|---|---|---|
| 2026-07-31 | +23.0% | $3.80 | 3.1M | No confirmed catalyst |
| 2026-07-14 | +40.5% | $4.16 | 53.4M | No confirmed catalyst |
| 2026-05-04 | +19.6% | $8.27 | 1.3M | No confirmed catalyst |
| 2026-05-01 | -32.8% | $6.92 | 1.8M | No confirmed catalyst |
About Shuttle Pharmaceuticals Holdings, Inc. Common Stock
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
SHPH — frequently asked
Why did SHPH stock move up on 2026-08-05?
No clear news behind the move — this looks driven by momentum rather than a specific catalyst. Finished the day strong — closed near its highs on heavy volume.
What is the SHPH stock price today?
The most recent close we hold for Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) is $3.21 on 2026-09-18, which is more recent than the 2026-08-05 move described above. Trader Club publishes end-of-day prices, not live quotes, so check your broker for the current price.
What is SHPH's 52-week range?
Over the past year of daily closes, SHPH has ranged between $2.78 and $47.60. That is the range of closing prices, not intraday highs and lows.
Has SHPH moved like this before?
Yes — we have 5 significant moves on record for SHPH, each at least 15% on heavy volume. They are listed with their dates above, including whether any news could be sourced for each one.
See it in context
SHPH opened +10.4% versus the prior close, then finished +14.1% from its open, on 1.6M shares traded.
Against the whole market that day, 38.2% of US stocks closed higher (median move -0.2%) — so SHPH rose even as most stocks fell. See the full market recap →
More movers: today's biggest gainers · today's biggest gap-ups · all screeners · why other stocks are moving
Learn the basics: how to read a chart · what volume means · grade SHPH’s chart with the AI reader →